These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 9692107)
1. The European Respiratory Society study on chronic obstructive pulmonary disease (EUROSCOP): recruitment methods and strategies. Löfdahl CG; Postma DS; Laitinen LA; Ohlsson SV; Pauwels RA; Pride NB Respir Med; 1998 Mar; 92(3):467-72. PubMed ID: 9692107 [TBL] [Abstract][Full Text] [Related]
2. European Respiratory Society study on chronic obstructive pulmonary disease (EUROSCOP): hypothesis and design. Pauwels RA; Löfdahl CG; Pride NB; Postma DS; Laitinen LA; Ohlsson SV Eur Respir J; 1992 Nov; 5(10):1254-61. PubMed ID: 1486974 [TBL] [Abstract][Full Text] [Related]
3. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial. Vestbo J; Sørensen T; Lange P; Brix A; Torre P; Viskum K Lancet; 1999 May; 353(9167):1819-23. PubMed ID: 10359405 [TBL] [Abstract][Full Text] [Related]
4. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. Pauwels RA; Löfdahl CG; Laitinen LA; Schouten JP; Postma DS; Pride NB; Ohlsson SV N Engl J Med; 1999 Jun; 340(25):1948-53. PubMed ID: 10379018 [TBL] [Abstract][Full Text] [Related]
5. Long term effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis. van Grunsven PM; van Schayck CP; Derenne JP; Kerstjens HA; Renkema TE; Postma DS; Similowski T; Akkermans RP; Pasker-de Jong PC; Dekhuijzen PN; van Herwaarden CL; van Weel C Thorax; 1999 Jan; 54(1):7-14. PubMed ID: 10343624 [TBL] [Abstract][Full Text] [Related]
6. Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group. Paggiaro PL; Dahle R; Bakran I; Frith L; Hollingworth K; Efthimiou J Lancet; 1998 Mar; 351(9105):773-80. PubMed ID: 9519948 [TBL] [Abstract][Full Text] [Related]
7. [Long-term effect of inhaled budesonide in patients with mild to moderate chronic obstructive lung disease. The Osterbro Study]. Vestbo J; Sørensen T; Lange P; Brix A; Torre P; Viskum K Ugeskr Laeger; 2000 Jan; 162(4):493-7. PubMed ID: 10697447 [TBL] [Abstract][Full Text] [Related]
8. Effects on diffusing capacity and ventilation--perfusion relationships of budesonide inhalations for 2 months in chronic obstructive pulmonary disease (COPD). Sandek K; Bratel T; Lagerstrand L Respir Med; 2001 Aug; 95(8):676-84. PubMed ID: 11530957 [TBL] [Abstract][Full Text] [Related]
9. Steroid reversibility test followed by inhaled budesonide or placebo in outpatients with stable chronic obstructive pulmonary disease. The Danish Society of Respiratory Medicine. Senderovitz T; Vestbo J; Frandsen J; Maltbaek N; Nørgaard M; Nielsen C; Kampmann JP Respir Med; 1999 Oct; 93(10):715-8. PubMed ID: 10581660 [TBL] [Abstract][Full Text] [Related]
10. Inhaled corticosteroids in COPD: the EUROSCOP study in perspective. Yernault JC Eur Respir J; 1992 Nov; 5(10):1169-70. PubMed ID: 1486959 [No Abstract] [Full Text] [Related]
11. Do patients with COPD benefit from treatment with inhaled corticosteroids? van Schayck CP; van Grunsven PM; Dekhuijzen PN Eur Respir J; 1996 Oct; 9(10):1969-72. PubMed ID: 8902451 [No Abstract] [Full Text] [Related]
12. Fixed ratio or lower limit of normal for the FEV Wollmer P; Frantz S; Engström G; Dencker M; Löfdahl CG; Nihlén U Clin Physiol Funct Imaging; 2017 May; 37(3):263-269. PubMed ID: 26443700 [TBL] [Abstract][Full Text] [Related]
13. Effects of long-term treatment with corticosteroids in COPD. Renkema TE; Schouten JP; Koëter GH; Postma DS Chest; 1996 May; 109(5):1156-62. PubMed ID: 8625660 [TBL] [Abstract][Full Text] [Related]
14. Randomised controlled trial of inhaled corticosteroids in patients with chronic obstructive pulmonary disease. Bourbeau J; Rouleau MY; Boucher S Thorax; 1998 Jun; 53(6):477-82. PubMed ID: 9713447 [TBL] [Abstract][Full Text] [Related]
15. Short-term treatment with budesonide does not improve hyperresponsiveness to adenosine 5'-monophosphate in COPD. Rutgers SR; Koëter GH; van der Mark TW; Postma DS Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):880-6. PubMed ID: 9517606 [TBL] [Abstract][Full Text] [Related]
16. An observational study of inhaled corticosteroid withdrawal in stable chronic obstructive pulmonary disease. ISOLDE Study Group. Jarad NA; Wedzicha JA; Burge PS; Calverley PM Respir Med; 1999 Mar; 93(3):161-6. PubMed ID: 10464871 [TBL] [Abstract][Full Text] [Related]
17. The response to inhaled and oral steroids in patients with stable chronic obstructive pulmonary disease. Weiner P; Weiner M; Rabner M; Waizman J; Magadle R; Zamir D J Intern Med; 1999 Jan; 245(1):83-9. PubMed ID: 10095821 [TBL] [Abstract][Full Text] [Related]
18. The importance of serum IgE for level and longitudinal change in airways hyperresponsiveness in COPD. Renkema TE; Kerstjens HA; Schouten JP; Vonk JM; Koëter GH; Postma DS Clin Exp Allergy; 1998 Oct; 28(10):1210-8. PubMed ID: 9824387 [TBL] [Abstract][Full Text] [Related]
19. The effect of inhaled corticosteroids on the development of emphysema in smokers assessed by annual computed tomography. Shaker SB; Dirksen A; Ulrik CS; Hestad M; Stavngaard T; Laursen LC; Maltbaek N; Clementsen P; Skjaerbaek N; Nielsen L; Stoel B; Skovgaard LT; Tonnesen P COPD; 2009 Apr; 6(2):104-11. PubMed ID: 19378223 [TBL] [Abstract][Full Text] [Related]